Ecolab (ECL)
NYSE:ECL
Want to see ECL full AI Analyst Report?
ECL Stock Chart & Stats
$274.80
$1.96(0.85%)
At close: 4:00 PM EST
$274.80
$1.96(0.85%)
Day’s Range― - ―
52-Week Range$243.15 - $309.27
Previous CloseN/A
Volume214.11K
Average Volume (3M)1.82M
Market Cap
$75.61B
Enterprise Value$84.47B
Total Cash (Recent Filing)$519.80M
Total Debt (Recent Filing)$9.27B
Price to Earnings (P/E)37.1
Beta0.57
Next Earnings
Jul 28, 2026EPS Estimate
2.08Next Dividend Ex-DateN/A
Dividend Yield1.01%
Share Statistics
EPS (TTM)7.44
Shares Outstanding281,437,500
10 Day Avg. Volume2,118,929
30 Day Avg. Volume1,820,544
Financial Highlights & Ratios
PEG Ratio-26.61
Price to Book (P/B)7.61
Price to Sales (P/S)4.62
P/FCF Ratio39.05
Enterprise Value/Market Cap1.12
Enterprise Value/Revenue5.13
Enterprise Value/Gross Profit11.59
Enterprise Value/Ebitda23.82
Forecast
1Y Price Target
$321.31Price Target Upside16.92% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering17
EPS Forecast (FY)8.31
Revenue Forecast (FY)$17.73B
Bulls Say, Bears Say
Bulls Say
Profitability & Margin ExpansionEcolab’s materially improved margins and stated 20% operating margin target reflect durable pricing power, SG&A discipline, and mix shift into higher‑margin services. Sustained margin expansion supports reinvestment, stronger free cash flow potential and resilient operating leverage over the medium term.
Recurring, Service‑Heavy ModelA business model built on consumable chemistries plus recurring on‑site services creates sticky revenue, high customer switching costs, and predictable replenishment. Cross‑selling and field service relationships support retention, pricing execution, and durable revenue visibility over multiple years.
Strategic M&A Into High‑Growth MarketsAcquisitions (OVIVO, pending CoolIT) and organic growth in Global High Tech, Life Sciences and digital pest intelligence reorient mix toward higher‑growth, higher‑margin end markets. This structural shift should lift long‑term growth potential, margins and resilience versus legacy cyclicals.
Bears Say
Weak Cash ConversionOperating cash conversion below earnings and a slight decline in free cash flow growth indicate working‑capital timing and earnings quality issues. Over time weaker cash conversion limits financial flexibility for buybacks, M&A integration funding and debt reduction versus peers with stronger conversion.
High Absolute Debt & FinancingAlthough leverage has fallen, a large absolute debt load plus recent multi‑billion acquisition financing increases exposure to rates and refinancing windows. Sustained high debt can constrain capital allocation, raise interest costs and magnify downside in macro stress or integration delays.
Exposure To Cyclical/Underperforming SegmentsOngoing weakness in paper and heavy industrial water end markets keeps a portion of revenue cyclically sensitive and margin dilutive. Prolonged sector softness would undermine consolidated growth and make delivery on margin targets harder despite strength in newer, faster segments.
Ecolab News
ECL FAQ
What was Ecolab’s price range in the past 12 months?
Ecolab lowest stock price was $243.15 and its highest was $309.27 in the past 12 months.
What is Ecolab’s market cap?
Ecolab’s market cap is $75.61B.
When is Ecolab’s upcoming earnings report date?
Ecolab’s upcoming earnings report date is Jul 28, 2026 which is in 33 days.
How were Ecolab’s earnings last quarter?
Ecolab released its earnings results on Apr 28, 2026. The company reported $1.7 earnings per share for the quarter, beating the consensus estimate of $1.695 by $0.005.
Is Ecolab overvalued?
According to Wall Street analysts Ecolab’s price is currently Undervalued.
Does Ecolab pay dividends?
Ecolab pays a Quarterly dividend of $0.73 which represents an annual dividend yield of 1.01%. See more information on Ecolab dividends here
What is Ecolab’s EPS estimate?
Ecolab’s EPS estimate is 2.08.
How many shares outstanding does Ecolab have?
Ecolab has 281,437,500 shares outstanding.
What happened to Ecolab’s price movement after its last earnings report?
Ecolab reported an EPS of $1.7 in its last earnings report, beating expectations of $1.695. Following the earnings report the stock price went down -0.343%.
Which hedge fund is a major shareholder of Ecolab?
Currently, no hedge funds are holding shares in ECL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Ecolab Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$321.31 (16.92% Upside)
$321.31 (16.92% Upside)
Blogger Sentiment
Bullish
ECL Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 589.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $155.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.0%
Last 30 Days ▲ 20.4%
Last 30 Days ▲ 20.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
4.64%
12-Months-Change
Fundamentals
Return on Equity
21.70%
Trailing 12-Months
Asset Growth
11.96%
Trailing 12-Months
Company Description
Ecolab
Ecolab Inc. delivers essential water, hygiene, and infection prevention products and services to clients across the United States and globally. The company organizes its operations into several key segments: Global Industrial, Global Institutional & Specialty, Global Healthcare & Life Sciences, and an "Other" segment. Through its Global Industrial division, Ecolab furnishes a range of water treatment, process applications, and cleaning and sanitizing solutions. These offerings cater to a diverse array of sectors including manufacturing, food and beverage processing, transportation, chemical production, metals and mining, power generation, pulp and paper, commercial laundries, and the petroleum, refining, and petrochemical industries. The Global Institutional & Specialty segment focuses on delivering specialized cleaning and sanitizing products primarily to the foodservice, hospitality, lodging, government and education, and retail sectors. Ecolab's Global Healthcare & Life Sciences segment addresses the needs of the healthcare, personal care, and pharmaceutical industries. It supplies specialized cleaning and sanitizing products, encompassing infection prevention, surgical solutions, and comprehensive cleaning and contamination control, marketed under brand names like Ecolab, Microtek, and Anios. Within the "Other" segment, Ecolab provides pest elimination services. These services aim to detect, eliminate, and prevent pests, including rodents and insects, for various clients such as restaurants, food and beverage processors, educational and healthcare institutions, hotels, quick service restaurants, grocery stores, and other commercial and institutional entities. This segment additionally furnishes colloidal silica, used for binding and polishing applications in the semiconductor, catalyst, aerospace component manufacturing, and chemical sectors. Furthermore, it delivers products and services for comprehensive wash process management, featuring custom-designed programs, premium products, dispensing equipment, water and energy conservation, and real-time data management. Ecolab distributes its offerings via its field sales and corporate account teams, as well as through a network of distributors and dealers. Established in 1923, the company maintains its headquarters in Saint Paul, Minnesota.
ECL Company Deck
ECL Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented strong, broad-based top-line momentum, margin expansion, and strategic M&A that accelerate exposure to high-growth, high-margin end markets (Global High Tech, Life Sciences, Pest Intelligence). Management acknowledged near-term headwinds from rising commodity and energy costs, a Q2 transition while surcharges roll in, and short-term EPS dilution from CoolIT financing/amortization, but provided clear plans and confidence that pricing, productivity and mix will offset these impacts with stable H2 margins and unchanged full-year EPS guidance (12%–15% ex-CoolIT). Overall the positives — diversified, accelerating growth engines, margin leverage and strong execution — substantially outweigh manageable, time-bound lowlights.View all ECL earnings summariesECL Net sales Breakdown
47.76% Global Water
37.07% Global Institutional & Specialty
4.39% Global Life Sciences
7.58% Global Pest Elimination
0.00% Corporate
3.20% Effect of foreign currency translation
ECL Stock 12 Month Forecast
Average Price Target
$321.31
▲(16.92% Upside)
Technical Analysis
Air Products and Chemicals
―
PPG Industries
―
RPM International
―
Steris
―
DuPont de Nemours
―
Ownership Overview
0.13% Insiders
17.41% Mutual Funds
18.21% Other Institutional Investors
41.06% Public Companies and
Individual Investors